Growth Metrics

Champions Oncology (CSBR) Other Working Capital Changes (2016 - 2026)

Champions Oncology has reported Other Working Capital Changes over the past 17 years, most recently at -$4.6 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 623.95% year-over-year to -$4.6 million; the TTM value through Jan 2026 reached -$4.6 million, down 106.19%, while the annual FY2025 figure was -$144000.0, 78.92% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was -$4.6 million at Champions Oncology, down from -$675000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.4 million in Q1 2023 and troughed at -$4.6 million in Q1 2026.
  • A 5-year average of -$244294.1 and a median of -$154000.0 in 2025 define the central range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 1502.34% in 2023 and fell as far as 778.49% in 2023.
  • Year by year, Other Working Capital Changes stood at -$124000.0 in 2022, then skyrocketed by 975.0% to $1.1 million in 2023, then plummeted by 108.48% to -$92000.0 in 2024, then plummeted by 633.7% to -$675000.0 in 2025, then tumbled by 583.85% to -$4.6 million in 2026.
  • Business Quant data shows Other Working Capital Changes for CSBR at -$4.6 million in Q1 2026, -$675000.0 in Q4 2025, and -$154000.0 in Q3 2025.